Not Yet Recruiting
Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer
NCT06365008
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Sun Yat-sen Memorial Hospital,Sun Yat-sen University Guangzhou, Guangdong, China